赛格列酮能抑制血管紧张素Ⅱ诱导的人内皮细胞表面粘附分子上调
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

广东省自然科学基金(04009589)


Ciglitazone Inhibits AngiotensinⅡ-induced Expressions of Adhesion Molecules in Human Endothelial Cells
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的研究赛格列酮对血管紧张素Ⅱ诱导人脐静脉内皮细胞表达细胞间粘附分子1和血管细胞粘附分子1上调的影响。方法以不同浓度的赛格列酮(0.1μmol/L、1μmol/L1、0μmol/L和100μmol/L)预处理人脐静脉内皮细胞24 h,再与10-7mmol/L血管紧张素Ⅱ共孵育12 h。通过半定量逆转录聚合酶链反应和Western Blot分别检测细胞间粘附分子1和血管细胞粘附分子1 mRNA和蛋白表达的情况。结果与血管紧张素Ⅱ组相比,0.1μmol/L和1μmol/L赛格列酮预处理24 h组对血管紧张素Ⅱ诱导人脐静脉内皮细胞表达细胞间粘附分子1 mRNA上调无抑制作用(1.107±0.091比1.104±0.081和1.062±0.051,p<0.05),而10μmol/L和100μmol/L组则有明显的抑制作用(0.814±0.016和0.766±0.026,p<0.01和p<0.001);细胞间粘附分子1蛋白表达分别下调52.9%和55.5%(p<0.01和p<0.001)。而不同浓度的赛格列酮(0.1μmol/L、1μmol/L、10μmol/L和100μmol/L)使血管细胞粘附分子mRNA表达分别下调14.2%、19.5%、45.1%和60.7%(0.1μmol/L时p<0.01,余p<0.001);蛋白表达分别下调17.8%、33.8%、54.5%和58.9%(0.1μmol/L时p<0.01,余p<0.001)。结论赛格列酮抑制血管紧张素Ⅱ上调人脐静脉内皮细胞表达血管细胞粘附分子1,并呈浓度依赖效应;但对细胞间粘附分子1无论是mRNA还是蛋白水平,在低浓度(0.1μmol/L和1μmol/L)时无抑制作用,在较高浓度(10μmol/L和100μmol/L)可有较明显的抑制作用。

    Abstract:

    Aim To examine the effects of Ciglitazone on the expressions of intercellular adhesion molecule(ICAM)-1 and vascular cell adhesion molecule(VCAM)-1 which were upregulated by AngⅡ. Methods Human umbilical vein endothelial cells(hUVEC) at passage 35 were pre-incubated for 24 h with Ciglitazone(0.1 μmol/L,1 μmol/L,10 μmol/L,and 100 μmol/L) before stimulated by 10-7 mmol/L AngⅡ for 12 h.Total RNA was extracted,and the expression of mRNA and protein of ICAM-1 and VCAM-1 was assessed by RT-PCR and Western Blot respectively. Results Ciglitazone at 0.1 μmol/L~100 μmol/L significantly attenuated the AngⅡ-induced expression of VCAM-1(0.1 μmmol/L p<0.01,the others p<0.001) both in mRNA and protein level.Ciglitazone(0.1 μmol/L,1 μmol/L) have no effects on the expression of ICAM-1(p<0.05),but inhibited the Ang Ⅱ-induced expression of ICAM-1 at 10 μmol/L or 100 μmol/L(p<0.01,p<0.001). Conclusions Pretreatment of Ciglitazone could inhibit AngⅡ-induced the expression of VCAM-1 and ICAM-1.These findings suggest that PPARγ agonist,currently used in treatment of type Ⅱ diabetes,may have beneficial effects in modulating inflammatory response in atherosclerosis.

    参考文献
    相似文献
    引证文献
引用本文

丁月霞,钟斌贝,孙吉力,刘启才,刘世明.赛格列酮能抑制血管紧张素Ⅱ诱导的人内皮细胞表面粘附分子上调[J].中国动脉硬化杂志,2006,14(11):945~948.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2005-12-01
  • 最后修改日期:2006-11-01
  • 录用日期:
  • 在线发布日期: